Hello, and welcome back to The Kable.
Variety, they say, is the spice of life. So we're actually beginning with excellent news this week. Regulators in Switzerland have approved the world's first malaria drug for use in newborn babies and underweight infants. The drug - a new formulation of Novartis' antimalarial Coartem, co-developed with Medicines for …